Kuo-Tung Tang1,2,3, Bo-Chueh Hsu4, Der-Yuan Chen5,6,7. 1. Division of Allergy, Immunology, and Rheumatology, Taichung Veterans General Hospital, Taichung, Taiwan. 2. Faculty of Medicine, National Yang-Ming University, Taipei, Taiwan. 3. Ph.D. Program in Translational Medicine and Rong Hsing Research Center for Translational Medicine, National Chung Hsing University, Taichung, Taiwan. 4. Division of Allergy, Immunology and Rheumatology, Taichung Veterans General Hospital Puli Branch, Nantou, Taiwan. 5. Translational Medicine Laboratory, China Medical University Hospital, Taichung, Taiwan. 6. Rheumatology and Immunology Center, China Medical University Hospital, Taichung, Taiwan. 7. College of Medicine, China Medical University, Taichung, Taiwan.
Abstract
Background: Numerous cases of the coronavirus disease 2019 (COVID-19) with autoimmune and rheumatic manifestations have been reported. Despite the available reviews that summarized its autoimmune/rheumatic manifestations, a systematic approach is still lacking. Therefore, we conducted a comprehensive systematic review in order to give an overview upon these rare but clinically significant manifestations. Methods: We performed a literature search of PubMed and EMBASE as of October 9, 2020. All articles relevant to either systemic or organ-specific autoimmune and rheumatic manifestations potentially associated with COVID-19 were collected. The reviewed literature were limited to adults ≥18 years. Results: Although most of the existing evidence was based on case reports or case series without a long-term follow-up, a variety of autoimmune/rheumatic manifestations were associated with COVID-19. The manifestations that have a consistent association with COVID-19 include autoimmune cytopenia, cutaneous vasculitis, encephalitis, and Guillain-Barre syndrome. Such association is conflicting as regards to antiphospholipid syndrome, hemophagocytic lymphohistiocytosis, and myasthenia gravis. Conclusion: Our systematic review indicated the potential of the COVID-19 virus to trigger a myriad of autoimmune and rheumatic manifestations, which should be considered amid global efforts to combat COVID-19.
Background: Numerous cases of the coronavirus disease 2019 (COVID-19) with autoimmune and rheumatic manifestations have been reported. Despite the available reviews that summarized its autoimmune/rheumatic manifestations, a systematic approach is still lacking. Therefore, we conducted a comprehensive systematic review in order to give an overview upon these rare but clinically significant manifestations. Methods: We performed a literature search of PubMed and EMBASE as of October 9, 2020. All articles relevant to either systemic or organ-specific autoimmune and rheumatic manifestations potentially associated with COVID-19 were collected. The reviewed literature were limited to adults ≥18 years. Results: Although most of the existing evidence was based on case reports or case series without a long-term follow-up, a variety of autoimmune/rheumatic manifestations were associated with COVID-19. The manifestations that have a consistent association with COVID-19 include autoimmune cytopenia, cutaneous vasculitis, encephalitis, and Guillain-Barre syndrome. Such association is conflicting as regards to antiphospholipid syndrome, hemophagocytic lymphohistiocytosis, and myasthenia gravis. Conclusion: Our systematic review indicated the potential of the COVID-19 virus to trigger a myriad of autoimmune and rheumatic manifestations, which should be considered amid global efforts to combat COVID-19.
Authors: Leora R Feldstein; Erica B Rose; Steven M Horwitz; Jennifer P Collins; Margaret M Newhams; Mary Beth F Son; Jane W Newburger; Lawrence C Kleinman; Sabrina M Heidemann; Amarilis A Martin; Aalok R Singh; Simon Li; Keiko M Tarquinio; Preeti Jaggi; Matthew E Oster; Sheemon P Zackai; Jennifer Gillen; Adam J Ratner; Rowan F Walsh; Julie C Fitzgerald; Michael A Keenaghan; Hussam Alharash; Sule Doymaz; Katharine N Clouser; John S Giuliano; Anjali Gupta; Robert M Parker; Aline B Maddux; Vinod Havalad; Stacy Ramsingh; Hulya Bukulmez; Tamara T Bradford; Lincoln S Smith; Mark W Tenforde; Christopher L Carroll; Becky J Riggs; Shira J Gertz; Ariel Daube; Amanda Lansell; Alvaro Coronado Munoz; Charlotte V Hobbs; Kimberly L Marohn; Natasha B Halasa; Manish M Patel; Adrienne G Randolph Journal: N Engl J Med Date: 2020-06-29 Impact factor: 91.245
Authors: Virginie Siguret; Sebastian Voicu; Marie Neuwirth; Maxime Delrue; Etienne Gayat; Alain Stépanian; Bruno Mégarbane Journal: Thromb Res Date: 2020-07-08 Impact factor: 3.944
Authors: Louise Bowles; Sean Platton; Nada Yartey; Minal Dave; Kurtis Lee; Daniel P Hart; Vickie MacDonald; Laura Green; Suthesh Sivapalaratnam; K John Pasi; Peter MacCallum Journal: N Engl J Med Date: 2020-05-05 Impact factor: 91.245
Authors: M Dominguez-Santas; B Diaz-Guimaraens; P Garcia Abellas; C Moreno-Garcia Del Real; P Burgos-Blasco; A Suarez-Valle Journal: J Eur Acad Dermatol Venereol Date: 2020-07-02 Impact factor: 9.228
Authors: Xabier Gutiérrez López de Ocáriz; Nerea Castro Quismondo; Elena Vera Guerrero; Mario Rodríguez Rodríguez; Rosa Ayala Díaz; Joaquín Martínez López Journal: Int J Lab Hematol Date: 2020-08-26 Impact factor: 2.877
Authors: Regina Larionova; K Byvaltsev; Оlga Kravtsova; Elena Takha; Sergei Petrov; Gevorg Kazarian; Anna Valeeva; Eduard Shuralev; Malik Mukminov; Yves Renaudineau; Marina Arleevskaya Journal: J Transl Autoimmun Date: 2022-04-12
Authors: Hareem Farooq; Muhammad Aemaz Ur Rehman; Abyaz Asmar; Salman Asif; Aliza Mushtaq; Muhammad Ahmad Qureshi Journal: J Taibah Univ Med Sci Date: 2021-09-28